Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sensei Biotherapeutics stock | $7.46

Learn how to easily invest in Sensei Biotherapeutics stock.

Sensei Biotherapeutics Inc
+ $0.87 ( + 11.11%)

Sensei Biotherapeutics Inc is a biotechnology business based in the US. Sensei Biotherapeutics shares (SNSE) are listed on the NASDAQ and all prices are listed in US Dollars. Sensei Biotherapeutics employs 30 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Sensei Biotherapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SNSE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Sensei Biotherapeutics stock price (NASDAQ: SNSE)

Use our graph to track the performance of SNSE stocks over time.

Sensei Biotherapeutics shares at a glance

Information last updated 2021-10-24.
Latest market close$7.46
52-week range$6.71 - $26.50
50-day moving average $9.65
200-day moving average $10.29
Wall St. target price$12.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.12

Buy Sensei Biotherapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sensei Biotherapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sensei Biotherapeutics price performance over time

Historical closes compared with the close of $7.46 from 2021-10-25

1 week (2021-10-20) 7.03%
1 month (2021-09-27) -32.18%
3 months (2021-07-27) 3.76%
6 months (2021-04-27) -44.04%
1 year (2020-10-23) N/A
2 years (2019-10-23) N/A
3 years (2018-10-23) N/A
5 years (2016-10-23) N/A

Sensei Biotherapeutics financials

Gross profit TTM $0
Return on assets TTM -103.29%
Return on equity TTM 0%
Profit margin 0%
Book value $5.33
Market capitalisation $215.6 million

TTM: trailing 12 months

Shorting Sensei Biotherapeutics shares

There are currently 525,867 Sensei Biotherapeutics shares held short by investors – that's known as Sensei Biotherapeutics's "short interest". This figure is 121% up from 237,937 last month.

There are a few different ways that this level of interest in shorting Sensei Biotherapeutics shares can be evaluated.

Sensei Biotherapeutics's "short interest ratio" (SIR)

Sensei Biotherapeutics's "short interest ratio" (SIR) is the quantity of Sensei Biotherapeutics shares currently shorted divided by the average quantity of Sensei Biotherapeutics shares traded daily (recently around 181333.44827586). Sensei Biotherapeutics's SIR currently stands at 2.9. In other words for every 100,000 Sensei Biotherapeutics shares traded daily on the market, roughly 2900 shares are currently held short.

To gain some more context, you can compare Sensei Biotherapeutics's short interest ratio against those of similar companies.

However Sensei Biotherapeutics's short interest can also be evaluated against the total number of Sensei Biotherapeutics shares, or, against the total number of tradable Sensei Biotherapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sensei Biotherapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Sensei Biotherapeutics shares in existence, roughly 20 shares are currently held short) or 0.025% of the tradable shares (for every 100,000 tradable Sensei Biotherapeutics shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sensei Biotherapeutics.

Find out more about how you can short Sensei Biotherapeutics stock.

Sensei Biotherapeutics share dividends

We're not expecting Sensei Biotherapeutics to pay a dividend over the next 12 months.

Sensei Biotherapeutics overview

Sensei Biotherapeutics, Inc. , a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.

Frequently asked questions

What percentage of Sensei Biotherapeutics is owned by insiders or institutions?
Currently 36.64% of Sensei Biotherapeutics shares are held by insiders and 16.543% by institutions.
How many people work for Sensei Biotherapeutics?
Latest data suggests 30 work at Sensei Biotherapeutics.
When does the fiscal year end for Sensei Biotherapeutics?
Sensei Biotherapeutics's fiscal year ends in December.
Where is Sensei Biotherapeutics based?
Sensei Biotherapeutics's address is: 1405 Research Boulevard, Rockville, MD, United States, 20850
What is Sensei Biotherapeutics's ISIN number?
Sensei Biotherapeutics's international securities identification number is: US81728A1088

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site